Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07452562) titled 'Hesperidin RCT in MS' on Feb. 28.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Swansea University

Condition: Multiple Sclerosis

Intervention: Dietary Supplement: Hesperidin

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: January 7, 2026

Target Sample Size: 60

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/study/NCT07452562

Published by HT Digital Content ...